KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Receivables (2016 - 2025)

Historic Receivables for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $10.8 million.

  • Biolife Solutions' Receivables fell 3949.1% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 3949.1%. This contributed to the annual value of $9.2 million for FY2024, which is 1608.0% up from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Receivables is $10.8 million, which was down 3949.1% from $10.1 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Receivables peaked at $33.9 million during Q4 2022, and registered a low of $7.9 million during Q4 2023.
  • For the 5-year period, Biolife Solutions' Receivables averaged around $20.0 million, with its median value being $20.2 million (2021).
  • As far as peak fluctuations go, Biolife Solutions' Receivables surged by 38478.51% in 2021, and later tumbled by 7672.68% in 2023.
  • Quarter analysis of 5 years shows Biolife Solutions' Receivables stood at $23.2 million in 2021, then skyrocketed by 46.17% to $33.9 million in 2022, then crashed by 76.73% to $7.9 million in 2023, then grew by 16.08% to $9.2 million in 2024, then increased by 18.26% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q3 2025, $10.1 million for Q2 2025, and $9.2 million during Q1 2025.